We are live on
!
Find out more
TCM
TimesSquare Capital Management Portfolio holdings
AUM
$6.8B
1-Year Est. Return
45.85%
This Fund
S&P 500
This Quarter
Est. Return
+3.2%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$7.19B
AUM Growth
+$18.8M
(+0.26%)
Cap. Flow
-$40.8M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
14.72%
Holding
203
New
14
Increased
81
Reduced
93
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$67.6M |
| 2 |
Ross Stores
ROST
|
+$52.8M |
| 3 |
Idexx Laboratories
IDXX
|
+$47.9M |
| 4 |
AZPN
Aspen Technology Inc
AZPN
|
+$45.8M |
| 5 |
Legend Biotech
LEGN
|
+$39.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$61M |
| 2 |
TransUnion
TRU
|
+$56.2M |
| 3 |
PACCAR
PCAR
|
+$51.6M |
| 4 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$48.3M |
| 5 |
Charles River Laboratories
CRL
|
+$43.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.74% |
| 2 | Industrials | 20.24% |
| 3 | Healthcare | 17.35% |
| 4 | Consumer Discretionary | 13.22% |
| 5 | Financials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVLR
176
DELISTED
Avalara, Inc.
AVLR
| $3.74M | 0.05% |
40,700
-466,495
| -92% | -$41.8M |
|
|
MNTV
177
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $2.13M | 0.03% |
365,800
-20,300
| -5% | -$158K |
|
178
Guardant Health
GH
$22.4B
| $1.84M | 0.03% |
34,200
-15,000
| -30% | -$770K |
|
179
Jack Henry & Associates
JKHY
$11B
| $1.7M | 0.02% |
9,350
-2,500
| -21% | -$490K |
|
|
COUP
180
DELISTED
Coupa Software Incorporated
COUP
| $1.59M | 0.02% |
27,100
-22,900
| -46% | -$1.5M |
|
|
DESP
181
DELISTED
Despegar.com
DESP
| $1.43M | 0.02% |
+250,550
| New | +$1.9M |
|
182
Humana
HUM
$46.3B
| $1.33M | 0.02% |
2,740
+15
| +0.6% | +$7.3K |
|
|
NVO
183
Novo Nordisk
NVO
$209B
| $1.26M | 0.02% |
+25,240
| New | +$1.35M |
|
184
Clean Harbors
CLH
$16.4B
| $1.24M | 0.02% |
11,300
| – | – |
|
185
Littelfuse
LFUS
$11.6B
| $646K | 0.01% |
3,250
-900
| -22% | -$215K |
|
186
DexCom
DXCM
$33.1B
| $644K | 0.01% |
+8,000
| New | +$678K |
|
187
Arcos Dorados Holdings
ARCO
$1.7B
| $547K | 0.01% |
+75,100
| New | +$541K |
|
188
RadNet
RDNT
$6.08B
| $527K | 0.01% |
+25,900
| New | +$522K |
|
|
NOTV
189
DELISTED
Inotiv
NOTV
| $281K | ﹤0.01% |
16,700
-8,400
| -33% | -$154K |
|
190
AbbVie
ABBV
$438B
| – | – |
-5,500
| Closed | -$842K |
|
191
Burlington
BURL
$23.4B
| – | – |
-274,000
| Closed | -$37.3M |
|
192
Evercore
EVR
$11.5B
| – | – |
-201,955
| Closed | -$18.9M |
|
193
Outset Medical
OM
$92.7M
| – | – |
-31,225
| Closed | -$6.96M |
|
194
OneSpaWorld
OSW
$2.62B
| – | – |
-3,141,000
| Closed | -$22.5M |
|
|
195
PACCAR
PCAR
$69.1B
| – | – |
-939,600
| Closed | -$51.6M |
|
196
Robert Half
RHI
$4.37B
| – | – |
-411,200
| Closed | -$30.8M |
|
|
WBA
197
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-8,800
| Closed | -$334K |
|
|
ENFN
198
DELISTED
Enfusion, Inc.
ENFN
| – | – |
-1,643,505
| Closed | -$16.8M |
|
|
ZEN
199
DELISTED
ZENDESK INC
ZEN
| – | – |
-407,500
| Closed | -$30.2M |
|
|
CCXI
200
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-41,700
| Closed | -$1.03M |
|
Similar funds
CF
JCAM
GAM
CIMLRA
SPC
SPS
BHM
MSE
TimesSquare Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, TimesSquare Capital Management held 203 positions worth $7.19B, up 0.26% from $7.17B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
TimesSquare Capital Management's Q3 2022 filing shows 14 new, 81 increased, 93 reduced and 14 closed positions. Its largest new stake was Aptiv: 704,300 shares worth $55.1M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $61M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.
- TimesSquare Capital Management's largest Q3 2022 buy was Aptiv: 704,300 shares worth $55.1M.
- TimesSquare Capital Management added most to Idexx Laboratories in Q3 2022, an estimated $47.9M increase.
- TimesSquare Capital Management's biggest Q3 2022 reduction was TransUnion, cutting an estimated $56.2M.
- TimesSquare Capital Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, selling an estimated $61M.
- TimesSquare Capital Management's ten largest holdings make up 15% of its $7.19B portfolio in Q3 2022.
- TimesSquare Capital Management opened 14 new positions and closed 14 in Q3 2022.
- TimesSquare Capital Management's portfolio value rose 0.26% quarter-over-quarter to $7.19B.
Based on TimesSquare Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.